معرفی
Andrew Camilli is a Professor in the Department of Molecular Biology and Microbiology at the Tufts University School of Medicine. His research focuses on understanding the life cycles of mucosal pathogens like Vibrio cholerae and Streptococcus pneumoniae, with aims to develop vaccines and treatments. He holds a PhD from the University of Pennsylvania (1992) and a BS from the University of Michigan (1985). His work includes pioneering studies on phage therapy, bacterial gene expression during infection, and desiccation survival mechanisms in pathogens.
Research Highlights:
- Development of phage-based prophylaxis for cholera prevention.
- Discovery of hyper-infectious states in V. cholerae and phage-mediated transmission antagonism.
- Identification of novel virulence factors in S. pneumoniae via mouse models.
- Creation of genetic tools widely adopted in microbial research.
Grants & Collaborations: Multiple NIH-funded projects on cholera persistence, phage therapy, and vaccine development. Collaborates with international teams on pathogen epidemiology and antimicrobial strategies.
Teaching: Directs Microbial Genetics courses for graduate students and contributes to advanced microbiology modules, emphasizing quantitative biology and phage therapy.
Awards: Recipient of the Distinguished Faculty Award (Tufts, 2014) and patents for cholera vaccines and diagnostic methods.
Labs & Teams: Leads a lab focused on bacterial pathogenesis, with interdisciplinary projects linking basic science to clinical applications.
